Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis
Soluble macrophage-derived CD163 is a marker of disease ABSTRACT
Objective. To investigate the expres-sion of the soluble form of the resident in ammatory cytokines in the in amed joint and are primarily present in the synovial lining, sub-lining layer and activity and progression in early rheumatoid arthritis
S.R. GreisenK. Stengaard-Pedersen1, H.J. Møller2M.L. Hetland3, , K. Hørslev-Petersen4,
A. Jørgensen5B. Deleuran31,3
, M. Hvid, 1,6, 1
Immunology, Institute of Medical Microbiology and 2Biochemistry and Department of Clinical 36
Rheumatology,University Hospital, Denmark; Institute of Clinical Medicine, Aarhus 4
Hospital, Denmark; Department of Rheumatology, Glostrup 5Hospital for Rheumatic Diseases, King Christian XUniversity of Southern Denmark, Denmark.
Stinne Ravn GreisenHolger Jon Møller
Kristian Stengaard-PedersenMerete Lund HetlandKim Hørslev-Petersen Annette Jørgensen Malene HvidBent Deleuran
Please address correspondence and reprint requests to: Dr B. Deleuran,
Institute of Medical Microbiology and Immunology,
Aarhus University, Building 1240, Wilhelm Meyers Allé 4,
DK-8000 Aarhus C, Denmark.
E-mail: b.deleuran@immunology.au.dkReceived on September 30, 2010; accepted in revised form on February 11, 2011.© Copyright EXPERIMENTALCLINICAL RHEUMATOLOGY AND
2011.
Key words:destruction, macrophages
CD163, arthritis, joint Competing interests: This work was
funded by Novo Nordisk (SRG unrestricted grant), Leo Pharma (MH unrestricted
grant), Danish Graduate School for In Vivo Pharmacology, the Danish Rheumatoid Association and The Institute of Clinical Medicine at the University of Aarhus.The authors have declared no competing interests.
macrophage marker CD163 (sCD163) and eters for disease activity, including ra-its association with core param-diographic matoid arthritis (RA).progression in early Methods.set measured from early In a longitudinal
rheu-sample at months initiation plasma RA patients (n=34) we of levels of sCD163 levels with disease activity in 28 joints of treatment treatment and and correlated after 9 (DAS28), erythrocyte C-reactive protein and measured plasma levels of sCD163 in total Sharp sedimentation score (TSS). rate (CRP), We (ESR) also 55 transverse healthy years sample volunteers set (HV) of and in a and plasma and joint uid.
OA of disease) patients RA chronic (>8 (n=24) patients with (n=24) paired Results.cantly higher plasma levels of sCD163 Early RA patients had signi -(1.69mg/l (1.42–2.10)) (median (IQR)) at baseline than after 9 months of treat-ment but (1.28mg/l (0.963–1.66), p=0.001), pared with HV (1.66mg/l (1.22–2.02)). not signi cantly changed com-In of early RA patients, baseline levels CRP sCD163, correlated with DAS28, at diographic progression (TSS) between 9 months and ESR. was Interestingly, associated with sCD163 ra-year 0 and 5 (r=0.468, p=0.02). Levels of sCD163 were higher in RA patients, than than in plasma.
in OA patients and higher in SF Conclusion.phage derived sCD163 are associated Plasma levels of macro-with diographic disease activity and predict ra-patients, supporting that sCD163 may progression in early RA-have a role as a biomarker of disease activity and that resident macrophages are important for joint destruction. Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune ease. sociated with cartilage destruction and Progression in ammatory of the disease joint is dis-as-synovial quently joint. result in ammation, in malformation which subse-represent Macrophages the major producers and broblasts of the of pro-689
cartilage pannus junction (1). The in l-trating macrophages express high levels of HLA-DR, tumour necrosis factor α (TNF-α), interleukin (IL-) 1 and IL-6, all known contributors to in ammation (2). Thus macrophages play an impor-tant mation and joint destruction, supported part in the progression of in am-by rophage association between synovial mac-progression.
in ltration and radiographic Macrophages in the joint are described as (3). M1 is believed to be the rst mac-two subpopulations, M1 and M2 rophage macrophages are especially found resi-at sites of in ammation. M2 dent in the joint and functionally attrib-uted to both pro- and anti-in ammatory activity elevated (4-6). M2 is characterised by receptor CD163.
expression of the scavenger CD163 and strongly regulated by external stim-is expressed by macrophages uli (7). IL-10, IL-6 and glucocorticoids upregulate lipopolysaccharide CD163 interferon γ (IFN-γ) result in downreg-(LPS), expression, TNF-α while and ulation of its surface expression (8). CD163 is also found in a soluble form (sCD163) due to ectodomain shedding by TNF-α converting enzyme (TACE), which lease of TNF-α (9). The soluble form is also responsible for the re-is in ammation upregulated in plasma during during chronic in ammation as in RA such as sepsis, but acute also (10). previously Plasma RA and spondylitis (11, 12).
been levels examined of sCD163 in chronic have In this study we investigated the asso-ciation rameters for disease activity as well as between sCD163 and core pa-joint destruction in early RA patients.Materials and methodsCollection of samples
A was longitudinal set of plasma samples study, with demographic data listed in obtained from the CIMESTRA Table I (14). The patients were newly diagnosed toms RA patients, with all entry corticosteroid for no longer than six months, symp-(n=34). Plasma naïve at samples the time were
of
Type-II IgG, IgM cell surface Min.-hrs Type-III IgG, IgM soluble 3-8... SLE Type-IV T cells cellular 48-72 hours or longer Macrophage & CTL ...
分类 ? 巨噬细胞集落刺激因子(macrophage-CSF,M-CSF) ? 粒细胞集落刺激因子...(soluble cytokine receptor,sCKR)是 细胞因子受体的一种特殊形式,其氨基酸的序列...
A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation[J]. Blood, 2007, 109(3):1026...
Eicosanoids Production of soluble factors Degranulation +/– NF- B TRAF6 ... while the ligand macrophage-activating lipopeptide-2, which binds to the ...
soluble cytokine receptors have effectively inhibited MIF activities, these ...M tautomerase inhibitor, and it also decreases macrophage TNFR production as ...
The potential of mannosylated chitosan microspheres to target macrophage ...Polymers and reagents Water-soluble chitosan (WSC, molecular weight, 100 kDa...
Two principle producer: – TH cell – macrophage 细胞因子的共同特性(详见《...-Membrane-bound cytokine receptor, mCKR -Soluble cytokine receptor, sCKR 3....
Macrophage β -1,3/1,6-glucan receptor a nutreco company TECHNICAL ...6 β-glucans Phospholipidic membrane Autolysis Yeast cell content Soluble ...
macrophage Fc receptors - an enhancing antibody CCR5 Fc receptor Anti-gp120...Soluble antibodies appear later against both surface and internal proteins ? ...
macrophage RAW 264.7 cells were plated into 96-well plate (5 × 105 ...Nitrite, a soluble oxidation product of NO, in the culture supernatanr, ...
热门文档